Kyoung E. Lee
Mokdong, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Analysis of the Frequency and Associated Factors of Skin Toxicity in Patients Receiving Ribociclib-Based Therapy for Metastatic Breast Cancer.
Journal: Cancers
Published: April 09, 2026
Predictive and Prognostic Value of p16 in Head and Neck Squamous Cell Carcinoma Patients Treated with Molecular Targeted Agents or Immune Checkpoint Inhibitors: Subgroup Analysis of the TRIUMPH Study.
Journal: Cancer investigation
Published: February 06, 2026
The moderating effect of team-based learning participation frequency on the relationship between medical students' perception of systematic team-based learning class management and active class participation.
Journal: Korean journal of medical education
Published: May 22, 2025
Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15).
Journal: Breast (Edinburgh, Scotland)
Published: January 06, 2025
Prevalence of germline BRCA1/2 pathogenic variants in unselected Korean patients with HER2-negative metastatic breast cancer: a nationwide prospective study (KCSG BR19-10).
Journal: The Lancet regional health. Western Pacific
Published: November 04, 2024
Proliferation of Tumor-Related Regulatory T Cells in Circulation Dictates Efficacy of Chemoimmunotherapy in Triple-Negative Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 03, 2024
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21).
Journal: BMC cancer
Published: September 06, 2024
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: June 11, 2024
Age- and ethnic-driven molecular and clinical disparity of East Asian breast cancers.
Journal: BMC medicine
Published: April 05, 2024
Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials.
Journal: Cancer research and treatment
Published: January 02, 2024
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15).
Journal: Therapeutic advances in medical oncology
Published: July 25, 2023
Last Updated: 09/26/2026